These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 991467)

  • 1. On the pathogenesis of Bartter's syndrome: report of studies in a patient with this disorder.
    Norby L; Mark AL; Kaloyanides GJ
    Clin Nephrol; 1976 Sep; 6(3):404-13. PubMed ID: 991467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma-aldosterone and renin activity in Bartter's syndrome (author's transl)].
    Rössler R
    Dtsch Med Wochenschr; 1975 Nov; 100(47):2443-8. PubMed ID: 171132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bartter's syndrome. New insights into pathogenesis and treatment.
    Solomon RJ; Brown RS
    Am J Med; 1975 Oct; 59(4):575-83. PubMed ID: 1166859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone and other mineralocorticoids in Bartter's syndrome.
    Saruta T; Fujimaki M; Senba S; Saito I; Konishi K
    J Lab Clin Med; 1984 Jun; 103(6):848-53. PubMed ID: 6373989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of blood pressure, plasma renin activity and plasma aldosterone concentration following the infusion of Sar1-Ile8-angiotensin II in hypertensive, fluid and electrolyte disorders.
    Yamamoto T; Doi K; Ogihara T; Ichihara K; Hata T; Kumahara Y
    Prog Biochem Pharmacol; 1976; 12():174-89. PubMed ID: 1019163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium.
    Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C
    J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of indomethacin in a patient with Bartter's syndrome: evidence against a primary role of prostaglandin in this disorder.
    Etzioni A; Chaimovitz C; Levi Y; Benderli A; Better OS
    Pediatr Res; 1980 Dec; 14(12):1395-7. PubMed ID: 7010289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial natriuretic peptide levels during angiotensin infusion and indomethacin administration are consistent with angiotensin-mediated regulation in man.
    Klemm SA; Tunny TJ; Gordon RD
    J Hypertens Suppl; 1987 Dec; 5(5):S75-8. PubMed ID: 2965235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal influence of salt intake on adrenal glomerulosa and renal vascular responses to angiotensin II in normal man.
    Hollenberg NK; Chenitz WR; Adams DF; Williams GH
    J Clin Invest; 1974 Jul; 54(1):34-42. PubMed ID: 4365595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of prostaglandins in the pathogenesis of Bartter's syndrome.
    Fichman MP; Telfer N; Zia P; Speckart P; Golub M; Rude R
    Am J Med; 1976 May; 60(6):785-97. PubMed ID: 798488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of renin and aldosterone during low-dose epinephrine infusion.
    Kruse HJ; Kreutz R; Staib S; Overlack A; Stumpe KO; Kolloch RE
    Am J Hypertens; 1994 Oct; 7(10 Pt 1):913-8. PubMed ID: 7826555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs.
    Kjolby MJ; Kompanowska-Jezierska E; Wamberg S; Bie P
    Acta Physiol Scand; 2005 Jul; 184(3):225-34. PubMed ID: 15954990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bartter's syndrome: Recurrence in the course of a treatment inhibiting prostaglandin synthesis].
    Favre L; Glasson P; Flory ED; Dray F; Vallotton MB
    Schweiz Med Wochenschr; 1979 Feb; 109(5):142-7. PubMed ID: 441720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bartter's syndrome--observations on the pathophysiology.
    Solomon LR; Bobinski H; Astley P; Goldby FS; Mallick NP
    Q J Med; 1982; 51(203):251-70. PubMed ID: 7146310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renin-angiotensin-aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance.
    Sellars L; Shore AC; Mott V; Wilkinson R
    Q J Med; 1985 Aug; 56(220):485-96. PubMed ID: 3901077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bartter's syndrome.
    Bartter FC
    Urol Clin North Am; 1977 Jun; 4(2):253-61. PubMed ID: 331616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical findings, pathogenesis and treatment of Bartter's syndrome (author's transl)].
    Ploier R; Tulzer W
    Wien Med Wochenschr; 1981; 131(11):287-93. PubMed ID: 7020264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal effects of the acute inhibition of angiotensin-converting enzyme. I. 2) Studies during moderate potassium depletion].
    Agnoli GC; Borgatti R; Cacciari M; Ikonomu E; Lenzi P; Marinelli M; Martello M
    Boll Soc Ital Biol Sper; 1992; 68(8-9):561-6. PubMed ID: 1294206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the effects of cicletanine on the renin-angiotensin-aldosterone system.
    Bippi H; Guinot P
    Drugs Exp Clin Res; 1988; 14(2-3):215-20. PubMed ID: 3046885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary kallikrein excretion in Bartter's syndrome.
    Lechi A; Covi G; Lechi C; Mantero F; Scuro LA
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1175-8. PubMed ID: 993321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.